Clinical trials recruiting in Netanya, Israel

Phase breakdown

Conditions recruiting in Netanya, Israel

Recruiting trials in Netanya, Israel

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
  NCT07011745 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
  NCT06937229 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
  NCT05133804 · Phase: Phase 2 · Ages: 20 Years to 60 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Netanya, Israel?

4 recruiting trials have at least one study site in Netanya, Israel.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.